Richter's Transformation Clinical Trials

15 clinical trials for Richter's Transformation across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CD45BE-HSPC + CART-45 Cells — RECRUITING · PHASE1
• Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader — RECRUITING · PHASE1
• ONO-4538 Study in Patients With Richter's Transformation — RECRUITING · PHASE2
• Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation — RECRUITING · PHASE2
• Registry of the German CLL Study Group — RECRUITING
• A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) — ACTIVE_NOT_RECRUITING · PHASE1
• Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas — TERMINATED · PHASE2
• Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia — TERMINATED · PHASE1
• PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) — TERMINATED · PHASE2
• Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation — TERMINATED · PHASE2
• Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation — TERMINATED · PHASE2
• Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma — TERMINATED · PHASE1
• Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation — TERMINATED · PHASE2
• Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL — COMPLETED · PHASE1
• Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias — COMPLETED · PHASE1

Refine this search